Treatment of Obesity With Topiramate in Patients With Polycystic Ovary Syndrome
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
Treatment of obesity related to Polycystic Ovary Syndrome with topiramate or placebo to
assess improvement of clinical and laboratory parameters after 6 months of follow-up